4.5 Article

Neural Cell Adhesion Molecule Stimulates Survival of Premyelinating Oligodendrocytes Via the Fibroblast Growth Factor Receptor

Journal

JOURNAL OF NEUROSCIENCE RESEARCH
Volume 87, Issue 15, Pages 3356-3368

Publisher

WILEY
DOI: 10.1002/jnr.22248

Keywords

oligodendrocyte; NCAM; myelination; cell signalling

Categories

Funding

  1. Medical Research Council

Ask authors/readers for more resources

Axonal signals are critical in promoting the survival and maturation of oligodendrocytes during myelination, with contact-dependent signals thought to play a key role. However, the exact nature of these signals remains unclear. Neural cell adhesion molecule (NCAM) is expressed by both axons and oligodendrocytes and is ideally localized to transduce signals from the axon. This study sought to investigate the influence of NCAM on premyelinating oligodendrocytes in vitro. Both a soluble molecule comprising the extracellular domain of NCAM and a peptide derived from the fibroblast growth factor receptor (FGFR) binding motif within the first fibronectin domain stimulated a dose-dependent increase in survival of premyelinating oligodendrocytes in vitro. The survival effect was blocked by a mitogen-activated protein kinase (MAPK) inhibitor and an FGFR inhibitor, suggesting that activation of MAPK signalling pathways following interaction with the FGFR is involved in the survival effect of NCAM. Furthermore, NCAM presented in a cellular monolayer induced an increase in radial process outgrowth of oligodendrocyte progenitor cells. These data suggest that NCAM may play a role in axon-oligodendrocyte signalling during myelination, leading to an increase in oligodendrocyte survival and process outgrowth following axonal contact. (C) 2009 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes

Maria L. Elkjaer, Arkadiusz Nawrocki, Tim Kacprowski, Pernille Lassen, Anja Hviid Simonsen, Romain Marignier, Tobias Sejbaek, Helle H. Nielsen, Lene Wermuth, Alyaa Yakut Rashid, Peter Hogh, Finn Sellebjerg, Richard Reynolds, Jan Baumbach, Martin R. Larsen, Zsolt Illes

Summary: Using proteomic approaches, 8 proteins were found to differentiate multiple sclerosis subtypes, with secondary progressive MS showing the largest difference from controls. The genes of these proteins were also present in MS brain lesions, suggesting potential biomarkers for differentiation.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration

Ynn van Olst, Carla Rodriguez-Mogeda, Carmen Picon, Svenja Kiljan, Rachel E. James, Alwin Kamermans, Susanne M. A. van der Pol, Lydian Knoop, Iliana Michailidou, Evelien Drost, Marc Franssen, Geert J. Schenk, Jeroen J. G. Geurts, Sandra Amor, Nicholas D. Mazarakis, Jack van Horssen, Helga E. de Vries, Richard Reynolds, Maarten E. Witte

Summary: The study identified two distinct microglial populations, MS1 and MS2, in the cortex of progressive MS patients, which differentially associate with neurodegeneration. Results suggest that microglia may initially protect neurons from meningeal inflammation-induced cell death by regulating synaptic location and phagocytosis, but over time, this protective property may be lost.

ACTA NEUROPATHOLOGICA (2021)

Article Clinical Neurology

Surface-in pathology in multiple sclerosis: a new view on pathogenesis?

Matteo Pardini, J. William L. Brown, Roberta Magliozzi, Richard Reynolds, Declan T. Chard

Summary: While multiple sclerosis can affect any part of the CNS, it does not do so evenly. Lesions tend to occur around the ventricles in white matter, and mainly in the outermost cortex in grey matter. Neuronal loss is greater in the outermost layers of cortical grey matter, with the most severe abnormalities near the ventricular surface. The cause of these gradients remains uncertain, but factors released from meningeal inflammation into the CSF may play a role.

BRAIN (2021)

Review Clinical Neurology

The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options

Qing Wang, Yuqi Luo, K. Ray Chaudhuri, Richard Reynolds, Eng-King Tan, Sven Pettersson

Summary: Parkinson's disease patients show unique changes in gut microbiota, which may serve as early biomarkers of the disease. The alterations in gut microbiota composition may be related to the cause and symptoms of Parkinson's disease, but the specific mechanisms remain unclear. The microbiota-gut-brain axis provides a new pathway for understanding the pathophysiology of Parkinson's disease.

BRAIN (2021)

Article Neurosciences

Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies

Haitao Tu, Zhi Wei Zhang, Lifeng Qiu, Yuning Lin, Mei Jiang, Sook-Yoong Chia, Yanfei Wei, Adeline S. L. Ng, Richard Reynolds, Eng-King Tan, Li Zeng

Summary: By systematically studying a series of AD and PD pathogenesis markers, as well as mitochondria, mitophagy, and neuroinflammation-related indicators, researchers have identified a set of signature proteins that can help understand the pathology and etiology of PDD and DLB at the molecular level. These findings provide valuable insights into distinguishing between PDD and DLB based on protein markers.

BMC NEUROSCIENCE (2022)

Article Clinical Neurology

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome

Benjamin J. Cooze, Matthew Dickerson, Rukshikah Loganathan, Lewis M. Watkins, Ethan Grounds, Ben R. Pearson, Ryan Jack Bevan, B. Paul Morgan, Roberta Magliozzi, Richard Reynolds, James W. Neal, Owain W. Howell

Summary: The extent of grey matter demyelination and neurodegeneration in the progressive multiple sclerosis (PMS) brains is associated with more severe disease. The thalamus in PMS is invariably affected by demyelination and has a higher proportion of active inflammatory lesions compared to forebrain cortical tissue. Thalamic neuronal loss is correlated with white matter pathology in other forebrain areas and disease duration and age of death.

BRAIN PATHOLOGY (2022)

Review Neurosciences

Diverse pathways to neuronal necroptosis in Alzheimer's disease

Anusha Jayaraman, Richard Reynolds

Summary: Necroptosis, a non-apoptotic cell death pathway, plays a significant role in Alzheimer's disease by involving multiple molecular mechanisms that interact and contribute to cellular vulnerability at different disease stages. Targeting these diverse pathways for therapeutic intervention remains a challenge due to their complex synergistic or inhibitory effects on each other.

EUROPEAN JOURNAL OF NEUROSCIENCE (2022)

Article Clinical Neurology

Ependymal-in Gradient of Thalamic Damage in Progressive Multiple Sclerosis

Roberta Magliozzi, Giulia Fadda, Robert A. Brown, Amit Bar-Or, Owain W. Howell, Simon Hametner, Damiano Marastoni, Alberto Poli, Richard Nicholas, Massimiliano Calabrese, Salvatore Monaco, Richard Reynolds

Summary: Leptomeningeal and perivenular infiltrates play important roles in cortical grey matter damage and disease progression in multiple sclerosis (MS). This study investigated the potential gradient of damage in deep grey matter nuclei and found substantial subependymal-in gradient of neuro-axonal loss and microglia activation in active thalamic lesions of progressive MS cases. The presence of increased leptomeningeal and cerebrospinal fluid (CSF) inflammation was associated with the altered graded pathology and more severe disease progression.

ANNALS OF NEUROLOGY (2022)

Article Clinical Neurology

Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration

Rachel E. James Bates, Eleanor Browne, Renee Schalks, Heather Jacobs, Li Tan, Puja Parekh, Roberta Magliozzi, Massimiliano Calabrese, Nicholas D. Mazarakis, Richard Reynolds

Summary: This study suggests that persistent increased levels of lymphotoxin-alpha in the cerebral meninges can lead to the formation of lymphoid-like structures and subsequent neurodegenerative and demyelinating pathology, similar to that seen in the progressive multiple sclerosis brain.

BRAIN (2022)

Article Immunology

Hypothesis of a potential BrainBiota and its relation to CNS autoimmune inflammation

Maria L. Elkjaer, Lukas Simon, Tobias Frisch, Lisa-Marie Bente, Tim Kacprowski, Mads Thomassen, Richard Reynolds, Jan Baumbach, Richard Roettger, Zsolt Illes

Summary: Infectious agents have been implicated in the development of neurological diseases due to their interaction with genetic susceptibility and the environment. The role of bacteria in central nervous system autoimmunity has been highlighted by changes in the gut microbiota of patients with diseases such as Parkinson's, Alzheimer's, and multiple sclerosis, emphasizing the importance of the gut-brain axis. This article discusses the hypothesis of a brain microbiota, known as BrainBiota, which refers to bacteria living in symbiosis with brain cells. Evidence suggests the presence of various bacteria in the human brain, including morphological evidence, bacterial proteins, metabolites, transcripts, and mucosal-associated invariant T cells. The authors propose that these bacteria are integral to brain development, immune tolerance, and are directly linked to the gut microbiome. They also suggest that changes in the BrainBiota during brain diseases may be either a consequence or a cause of chronic inflammation, similar to the gut microbiota.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

The link between neuroinflammation and the neurovascular unit in synucleinopathies

Qing Wang, Jialing Zheng, Sven Pettersson, Richard Reynolds, Eng-King Tan

Summary: The neurovascular unit (NVU) consists of vascular cells, glial cells, and neurons. It plays an important role in maintaining the microenvironment homeostasis and the integrity of the blood-brain barrier. Disruption of the NVU and interactions among its components are involved in the pathophysiology of synucleinopathies, characterized by pathological accumulation of α-synuclein. Neuroinflammation contributes to the pathophysiology of synucleinopathies such as Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies. This review summarizes the neuroinflammatory response of glial cells and vascular cells in the NVU, as well as the cross-talk between different cell types within the NVU and the influence of α-synuclein on neuroinflammation and disease progression.

SCIENCE ADVANCES (2023)

Review Immunology

Lysosomal acidification dysfunction in microglia: an emerging pathogenic mechanism of neuroinflammation and neurodegeneration

Joseph D. Quick, Cristian Silva, Jia Hui Wong, Kah Leong Lim, Richard Reynolds, Anna M. Barron, Jialiu Zeng, Chih Hung Lo

Summary: Microglia are innate immune cells in the brain that play a crucial role in immune responses and defense in the central nervous system. They are responsible for phagocytic and autophagic clearance of waste and toxic proteins, relying on lysosomal acidification. Impaired lysosomal acidification in microglia leads to dysfunction and neurodegeneration, while reacidification can reverse neurodegenerative pathology.

JOURNAL OF NEUROINFLAMMATION (2023)

Review Clinical Neurology

Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis

Roberta Magliozzi, Owain W. Howell, Massimiliano Calabrese, Richard Reynolds

Summary: Growing evidence suggests a central role for meningeal inflammation in driving multiple sclerosis (MS) pathology. The subarachnoid space and associated meningeal spaces play important roles in the entry and diffusion of immune cells and molecules into the brain tissue. Chronic meningeal inflammation is associated with a more severe clinical course of MS.

NATURE REVIEWS NEUROLOGY (2023)

Meeting Abstract Clinical Neurology

Neuronal loss in the thalamus and pons correlates with disease severity: Interim analysis of a large digital pathology study

B. Cooze, I. Farkas, Y. Leung, H. Yadanar, K. Gerhards, D. Gveric, R. Nicholas, J. W. Neal, D. R. Owen, R. Reynolds, O. W. Howell

MULTIPLE SCLEROSIS JOURNAL (2022)

Review Clinical Neurology

Tissue donations for multiple sclerosis research: current state and suggestions for improvement

Patrick Vanderdonckt, Francesca Aloisi, Giancarlo Comi, Alexander de Bruyn, Hans-Peter Hartung, Inge Huitinga, Tanja Kuhlmann, Claudia F. Lucchinetti, Imke Metz, Richard Reynolds, Hans Lassmann

Summary: The article discusses the significance of brain tissues in multiple sclerosis research and suggests ways to increase the availability of suitable material. The authors propose methods to increase tissue donation and the creation of a registry for accessible tissues.

BRAIN COMMUNICATIONS (2022)

No Data Available